- Home
- CLSD vs IRAA Comparison
CLSD vs IRAA Comparison
Compare CLSD & IRAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLSD
- IRAA
- Stock Information
- Founded
- CLSD 2011
- IRAA 2020
- Country
- CLSD United States
- IRAA Cayman Islands
- Employees
- CLSD N/A
- IRAA N/A
- Industry
- CLSD Biotechnology: Pharmaceutical Preparations
- IRAA Blank Checks
- Sector
- CLSD Health Care
- IRAA Finance
- Exchange
- CLSD Nasdaq
- IRAA Nasdaq
- Market Cap
- CLSD 75.5M
- IRAA 77.3M
- IPO Year
- CLSD 2016
- IRAA 2021
- Fundamental
- Price
- CLSD $0.97
- IRAA $11.05
- Analyst Decision
- CLSD Strong Buy
- IRAA
- Analyst Count
- CLSD 6
- IRAA 0
- Target Price
- CLSD $4.83
- IRAA N/A
- AVG Volume (30 Days)
- CLSD 253.4K
- IRAA 1.7K
- Earning Date
- CLSD 08-12-2024
- IRAA 01-01-0001
- Dividend Yield
- CLSD N/A
- IRAA N/A
- EPS Growth
- CLSD N/A
- IRAA N/A
- EPS
- CLSD N/A
- IRAA N/A
- Revenue
- CLSD $7,524,000.00
- IRAA N/A
- Revenue This Year
- CLSD N/A
- IRAA N/A
- Revenue Next Year
- CLSD $445.55
- IRAA N/A
- P/E Ratio
- CLSD N/A
- IRAA N/A
- Revenue Growth
- CLSD 365.02
- IRAA N/A
- 52 Week Low
- CLSD $0.65
- IRAA $10.30
- 52 Week High
- CLSD $2.12
- IRAA $12.49
- Technical
- Relative Strength Index (RSI)
- CLSD 38.05
- IRAA 53.21
- Support Level
- CLSD $0.92
- IRAA $10.50
- Resistance Level
- CLSD $1.03
- IRAA $11.23
- Average True Range (ATR)
- CLSD 0.04
- IRAA 0.04
- MACD
- CLSD -0.00
- IRAA 0.03
- Stochastic Oscillator
- CLSD 38.46
- IRAA 92.44
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
About IRAA Iris Acquisition Corp
Iris Acquisition Corp is a blank check company.